<DOC>
	<DOC>NCT01193127</DOC>
	<brief_summary>The purpose of this study is to determine whether the use of OMS302 (the study drug) in individuals undergoing Cataract Extraction with Lens Replacement (CELR) surgery is safe and effective at maintaining an adequately dilated pupil during surgery and reducing post-operative symptoms of discomfort (such as eye pain and irritation).</brief_summary>
	<brief_title>Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR)</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Mydriatics</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Competent and willing to voluntarily provide informed consent 18 years of age or older In good general health needing to undergo cataract extraction with lens replacement surgery in one eye, under topical anesthesia Other inclusion criteria to be evaluated by the investigator No allergies to the medications and/or the active ingredients of any of the study medications No medications with the same activities as the of the active ingredients in OMS302 for defined time intervals prior to and after surgery No other significant eye injuries, eye conditions or general medical conditions likely to interfere with the evaluation of the study medication Other exclusion criteria to be evaluated by the investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>